However, unlike patients from Western countries, who have a low frequency (between 10% and 20%) of p53 mutations, patients with HCC from Southeast Asia (e.g., China and Japan) harbor a high frequency (up to 60%) of p53 mutations owing to chronic hepatitis B infection and aflatoxin B1 exposure (11, 12). Here, TP53 is linked to hepatocellular carcinoma.